selected scholarly activity
-
chapters
- Management of immune‐mediated thrombocytopenia. 402-423. 2022
- Acquired Thrombocytopenia. 135-148. 2019
- Immune Thrombocytopenia. 127-144. 2019
- Chapter 131 Diseases of Platelet Number Immune Thrombocytopenia, Neonatal Alloimmune Thrombocytopenia, and Posttransfusion Purpura. 1944-1954. 2018
- Diseases of Platelet Number. 1944-1954. 2018
- Diseases of Platelet Number: Immune Thrombocytopenia, Neonatal Alloimmune Thrombocytopenia, and Posttransfusion Purpura. 1944-1954. 2017
- Management of immune‐mediated thrombocytopenia. 245-264. 2016
- The intensive care unit. European Respiratory Monograph. 85-89. 2013
- Red cell, platelet, and white cell antigens. 509-546. 2013
- Getting the Most Out of the Evidence for Transfusion Medicine. 505-515. 2013
- Acquired hemolytic anemia. 157-172. 2011
- Acquired hemolytic anemia. 157-172. 2011
- CHAPTER 10 Acquired hemolytic anemia. 157-172. 2011
- Management of Immune Thrombocytopenia. 344-375. 2009
- Thrombocytopenia and thrombocytosis. 983-1005. 2007
-
conferences
- P‐TS‐7 | An Evaluation of Plasma Transfusion Practices: A 10‐Year Retrospective Study. Transfusion. 258A-259A. 2023
- MRI, Efficacy, and Safety of Tolebrutinib in Highly Active Disease: 2-Year Data from Phase 2b Long-term Safety Study. European Journal of Neurology. 526-527. 2023
- Serum neurofilament light chain levels during natalizumab treatment with every-4-week and every-6-week dosing in NOVA. European Journal of Neurology. 528-529. 2023
- Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress. Research and Practice in Thrombosis and Haemostasis. 100193-100193. 2023
- PATHOGENESIS OF PLATELET PROTHROMBOTIC STATES (HITT/VITT). American Journal of Hematology. E7-E8. 2023
- Challenges of containerization and robotization the telescope control system for large robotic telescope. Proceedings of SPIE - The International Society for Optical Engineering. 2022
- Challenges of the telescope control system for large robotic telescopes. Proceedings of SPIE - The International Society for Optical Engineering. 2020
- Transfusion Reactions Following the Implementation of Seven Day Platelets. Transfusion. 256A-256A. 2020
- A Regional Massive Hemorrhage Protocol: Designed with a Modified Delphi Technique to Obtain Consensus. Blood. 5792-5792. 2019
- Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study. Blood. 3518-3518. 2019
- Identifying Patterns of Inappropriate Plasma Transfusion Practices Using a Novel Multicenter Electronic Data Audit: Over 80 Percent of Plasma Transfused Is Inappropriate. Blood. 3695-3695. 2019
- Impact of Iron Supplementation on Patient Outcomes in Women Undergoing Gynecological Procedures: Systematic Review and Meta-Analysis of Randomized Trials. Blood. 59-59. 2019
- Pathogenic Antibodies in Heparin-Induced Thrombocytopenia Specifically Target an Immunodominant Region on Platelet Factor 4. Blood. 219-219. 2019
- Perioperative Eltrombopag or Intravenous Immune Globulin for Patients with Immune Thrombocytopenia: A Multicenter Randomized Trial. Blood. 896-896. 2019
- Physicians' and Patients' Perspectives on Treatments in ITP - a Multi-Country Perspective: Results from the ITP World Impact Survey (I-WISh). Blood. 1097-1097. 2019
- Second-Line Therapy for Immune Thrombocytopenia: Real-World Experience. Blood. 2120-2120. 2019
- Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS): A Pragmatic Stepped Wedge Cluster Randomized Trial. Blood. 3685-3685. 2019
- Sex‐mismatched red blood cell transfusions and mortality: A systematic review and meta‐analysis. Vox Sanguinis. 505-516. 2019
- FOSTAMATINIB, A SPLEEN TYROSINE KINASE INHIBITOR, IS ACTIVE IN THE TREATMENT OF WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA: RESULTS OF THE SOAR PHASE 2, MULTICENTER, OPEN-LABEL STUDY. American Journal of Hematology. E34-E35. 2018
- IMPROVING LABORATORY TESTING FOR HEPARIN INDUCED THROMBOCYTOPENIA. American Journal of Hematology. E47-E48. 2018
- Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia. Blood. 234-241. 2018
- Anti-CD20 Monoclonal Antibody Therapy for Immune Modulation Across a Range of Autoimmune Diseases. Blood. 2017
- Emergency Management of Patients with Immune Thrombocytopenia and Severe Bleeding. Blood. 2017
- Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results. Blood. 2017
- Performance Characteristics of a Novel Platelet Viability Assay for Heparin-Induced Thrombocytopenia. Blood. 2017
- The Identification of the Amino Acids on Platelet Factor 4 That Bind Pathogenic Antibodies in Heparin-Induced Thrombocytopenia. Blood. 2017
- Analysis of Red Blood Cell Storage Duration and in-Hospital Mortality Using Time Dependent Exposure: Is the Oldest Blood Bad?. Transfusion. 33A-33A. 2017
- Megakaryocyte Apoptosis in the Bone Marrow of Patients with Immune Thrombocytopenia. Blood. 1379-1379. 2016
- The Effect of Platelet Transfusion on Death in the Intensive Care Unit. Blood. 3850-3850. 2016
- Developing a Data-driven Research Program: An Integrated Database Network Tool Driving Education and Research Forward. Transfusion. 237A-237A. 2016
- Informing Fresh Versus Old Red Cell Management (INFORM) Trial: A Large International Pragmatic Randomized Trial. Transfusion. 5A-5A. 2016
- Five-Year Outcomes of Halt-MS: High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Severe Relapsing-Remitting Multiple Sclerosis. Bone Marrow Transplantation. S61-S62. 2016
- Exploratory Analysis of a Blood Processing Method and In-hospital Mortality. Transfusion. 23A-23A. 2015
- Group O Red Blood Cells: Where is Universal donor blood Being Used?. Transfusion. 153A-154A. 2015
- Red Blood Cell Transfusion Antigen Matching Influence on Gestational Outcomes (AMIGO) Study. Transfusion. 25A-25A. 2015
- Higher or lower dose corticosteroids for primary immune thrombocytopenia: systematic review and meta-analysis. Journal of Thrombosis and Haemostasis. 40-40. 2015
- Interventions to reduce blood loss from laboratory testing in critically ill patients and impact on transfusion: a systematic review. Journal of Thrombosis and Haemostasis. 974-975. 2015
- A Phase II Study Evaluating the Efficacy of Rituximab in the Management of Patients with Relapsed or Refractory TTP. Blood. 4191-4191. 2014
- Difficulties in Establishing the Cause of Thrombocytopenia Among Ambulatory Patients Referred to Hematology: An Agreement Study. Blood. 3521-3521. 2014
- The Mcmaster ITP Registry: Assessing the Prevalence, Clinical and Laboratory Features of Immune Thrombocytopenia. Blood. 5008-5008. 2014
- lLow Level Platelet-Activating Antibodies in Patients Suspected of Having Heparin-Induced Thrombocytopenia but Testing Negative in the "Gold Standard" Functional Test. Blood. 2014
- Systematic Review and Meta-Analysis Of Rituximab For The Treatment Of Immune Thrombocytopenia In Adults. Blood. 1681-1681. 2013
- Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI). Transplantation and Cellular Therapy. S129-S129. 2013
- Persistent Impairments in Humoral and Cellular Immunity in Patients with Immune Thrombocytopenia Treated with Rituximab: A Sub-Study of a Randomized Controlled Trial. Blood. 2012
- Persistent Impairments in Humoral and Cellular Immunity in Patients with Immune Thrombocytopenia Treated with Rituximab: A Sub-Study of a Randomized Controlled Trial. Blood. 492-492. 2012
- Reporting Bleeding Outcomes in Adult and Pediatric Studies of Primary Immune Thrombocytopenia: A Systematic Review. Blood. 4281-4281. 2012
- Use of Intravenous Immune Globulin in Patients with Immune Thrombocytopenia Before and After Romiplostim: Real-World Experience. Blood. 4641-4641. 2012
- RINGO3: a multi-colour fast response polarimeter. Proceedings of SPIE - The International Society for Optical Engineering. 2012
- Prothrombin Complex Concentrates Reduce Blood Loss in Mice Rendered Coagulopathic by Warfarin but Not Dabigatran Etexilate. Transfusion. 56A-57A. 2012
- Quality of reporting of surveys in critical care journals. Critical Care Medicine. 441-449. 2012
- Bone Marrow Specimens From Patients with Immune Thrombocytopenia (ITP) Demonstrate Increased Megakaryocyte-Bound IgG and Increased T-Helper Cells. Blood. 972-972. 2011
- Identifying Drugs Implicated in Drug-Induced Immune Thrombocytopenia Using Levels of Evidence Applied to Laboratory Tests. Blood. 1421-1421. 2011
- Can We Do a 25,000 Patient Pragmatic Study to Address the Age of Blood and Mortality Controversy? A Pilot to Determine Feasibility. Transfusion. 193A-193A. 2011
- Quality Of Reporting Of Surveys In Critical Care Journals: A Methodologic Review. A104. INTENSIVE CARE UNIT ORGANIZATION, OUTCOMES, AND RESEARCH. a2390-a2390. 2011
- The Utility of Bone Marrow Examinations for the Diagnosis of Immune Thrombocytopenia. Blood. 1514-1514. 2010
- Understanding Treatment Preferences In Patients with Primary Immune Thrombocytopenia Contemplating Splenectomy: A Qualitative Study. Blood. 176-176. 2010
- A Multifaceted Strategy to Reduce Inappropriate Use of Fresh Frozen Plasma Transfusions in the Intensive Care Unit.. Blood. 575-575. 2009
- Adjudicating Bleeding Outcomes in a Large Thromboprophylaxis Trial in Critical Illness. Blood. 974-974. 2009
- Passive Transfer of Hepatitis B Core Antibody by Intravenous Immune Globulin-in Patients with Immune Thrombocytopenic Purpura. Blood. 955-955. 2009
- PSY38 ELICITING HEALTH STATE UTILITIES FOR IMMUNE (IDIOPATHIC) THROMBOCYTOPENIC PURPURA: RESULTS OF A GENERAL PUBLIC BASED TIME TRADE-OFF SURVEY. Value in Health. A382-A382. 2009
- A Mouse Model to Assess the Efficacy of Plasma Transfusion in the Prevention of Bleeding. Transfusion. 31A-31A. 2009
- The Development of a Bleeding Severity Measurement Scale (BSMS): A New Measurement Tool. Transfusion. 165A-165A. 2009
- A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura. Kidney International, Supplement. S55-S58. 2009
- Autoantibodies in Patients with ITP Do Not Bind to Patient-Specific Epitopes on Platelet Glycoproteins. Blood. 1175-1175. 2008
- The Efficacy of H. pylori Eradication Therapy in H. pylori-Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review. Blood. 1170-1170. 2008
- Development of a mouse model for assessing the efficacy of plasma transfusion in reducing bleeding. Transfusion. 142A-142A. 2008
- Refractory thrombotic thrombocytopenic purpura in a patient with waldenstroms macroglobulinemia. Transfusion. 49A-50A. 2008
- A Generalization of the Blahut–Arimoto Algorithm to Finite-State Channels. IEEE Transactions on Information Theory. 1887-1918. 2008
- An individual platelet count set-point in ITP: A concept learned from patients with mild thrombocytopenia and a good response to IVIg or corticosteroids. Blood. 49B-49B. 2007
- Incidence of HPA-9b in Testing for Neonatal Alloimmune Thrombocytopenia.. Blood. 3214-3214. 2007
- Peripartum Management of Women with Suspected Hereditary Thrombocytopenia.. Blood. 3224-3224. 2007
- A systematic review and meta-analysis of platelets prepared from apheresis versus whole blood. Transfusion. 190A-190A. 2007
- An algorithm for "indeterminate" test results in the platelet serotonin release assay for heparin-induced thrombocytopenia (HIT).. Blood. 312A-312A. 2006
- Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura: A case report. Transfusion. 44A-45A. 2006
- Simulation-Based Computation of Information Rates for Channels With Memory. IEEE Transactions on Information Theory. 3498-3508. 2006
- Rituximab for the treatment of adults with ITP: A systematic review. Blood. 361A-361A. 2005
- The HPA-15 (Gov) Platelet Alloantigen System: Allele Frequencies in the Canadian Population.. Blood. 2180-2180. 2005
- Proceedings of a Consensus Conference: Towards an Understanding of TRALI. Transfusion Medicine Reviews. 2-31. 2005
- Regular and irregular progressive edge-growth tanner graphs. IEEE Transactions on Information Theory. 386-398. 2005
- Platelet Transfusions in a Medical- Surgical Intensive Care Unit.. Blood. 3637-3637. 2004
- Survival of HIV infected individuals with hemophilia after 20 years: From the Canadian Hemophilia Registry.. Blood. 842A-843A. 2004
- The Effect of Prophylactic Administration of Myeloid Growth Factors Following Autologous Stem Cell Transplantation for Patients with Hematological Malignancies: A Systematic Review.. Blood. 2192-2192. 2004
- The Use of Aprotinin to Reduce Transfusion Requirements in Children Undergoing Cardiac Surgery: A Meta-Analysis.. Blood. 2718-2718. 2004
- A randomized crossover trial comparing in-vivo platelet recovery and survival of leukoreduced apheresis and whole blood derived platelets. Transfusion. 1A-1A. 2004
- On the data-processing inequality in the mismatch case. 2004 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY, PROCEEDINGS. 266-266. 2004
- Severe hypotension following transfusion of pre-storage leukoreduced red blood cells and acute normovolemic hemodilution whole blood. Transfusion. 112A-112A. 2003
- International Conferences on Abelian Group Theory: The First Forty Years. Rocky Mountain Journal of Mathematics. 1153-1160. 2002
- Cardiobacterium hominis endocarditis masquerading as very severe refractory immune thrombocytopenic purpura: Report of a case.. Blood. 83B-84B. 2002
- Pension guaranty programs: US and Canada. RECORD - SOCIETY OF ACTUARIES, VOL 20, NO 4A AND 4B. 1117-1132. 1995
- TORSION FREE ABELIAN QPI AND QPP GROUPS - PRELIMINARY-REPORT. Notices of the American Mathematical Society. A91-A91. 1976
-
journal articles
- 2022 Review of the 2019 American Society of Hematology Guidelines on Immune Thrombocytopenia. Blood Advances. bloodadvances.2023012541. 2024
- Evaluation of a diagnostic platelet aggregation test strategy for platelet rich plasma samples with low platelet counts. International Journal of Laboratory Hematology. 46:362-374. 2024
-
Quality of life and
cost‐effectiveness of convalescent plasma compared to standard care for hospitalizedCOVID ‐19 patients in theCONCOR ‐1 trial. Transfusion. 64:606-614. 2024 - Targeted ADAMTS-13 replacement therapy for thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 22:896-904. 2024
- Bleeding self‐assessments by patients with immune thrombocytopenia (ITP): An agreement study. American Journal of Hematology. 2024
- Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P’s) for anti-PF4 diseases. Expert Review of Hematology. 17:39-45. 2024
- 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19. Journal of Thrombosis and Haemostasis. S1538-7836(24)00113-2. 2024
- Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada. Clinical and Investigative Medicine. 47:13-22. 2024
- Treatment of critical bleeding events in patients with immune thrombocytopenia: a protocol for a systematic review and meta-analysis. Systematic Reviews. 13:21. 2024
- Evaluation of laboratory testing parameters for vaccine-induced immune thrombotic thrombocytopenia and their implications for diagnosis. Journal of Thrombosis and Haemostasis. 22:304-306. 2024
- Prevalence and significance of large granular lymphocytes in patients with immune thrombocytopenia. Platelets. 34:2144194. 2023
- An unsupervised learning approach to identify immunoglobulin utilization patterns using electronic health records. Transfusion. 63:2234-2247. 2023
- Evaluation of Bleeding Self-Assessments By Patients with Immune Thrombocytopenia (ITP): An Agreement Study. Blood. 142:3958-3958. 2023
- The Lack of Tolerable Treatments Options That Can Induce Durable Responses without Fear of Relapse after Discontinuation Represents a Significant Unmet Need for Patients (Pts) with Immune Thrombocytopenia (ITP): Results from the ITP World Impact Survey (I-WISh) 2.0. Blood. 142:1212-1212. 2023
- Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care. Journal of the American Medical Association (JAMA). 330:1872-1872. 2023
- Data-driven fair resource allocation for novel emerging epidemics: a COVID-19 Convalescent Plasma case study. INFOR: Information Systems and Operational Research. 61:559-588. 2023
- Inhibition of neonatal Fc receptor as a treatment for immune thrombocytopenia. The Lancet. 402:1599-1601. 2023
- Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia. Journal of Thrombosis and Haemostasis. 21:2833-2843. 2023
- PB0343 Longitudinal Study on the Persistence of Anti-Platelet Factor 4 Antibodies in Vaccine-Induced Immune Thrombotic Thrombocytopenia after 14 Months. Research and Practice in Thrombosis and Haemostasis. 7:101485-101485. 2023
- PB0350 Prospective Study to Evaluate the Consolidated Performance of Two Automated Rapid Assays for the Diagnosis of Heparin-Induced Thrombocytopenia. Research and Practice in Thrombosis and Haemostasis. 7:101480-101480. 2023
- P‐BB‐8 | A Survey to Understand C1 Esterase Inhibitor Distribution Patterns and Use in Canada. Transfusion. 63:94A-95A. 2023
- P‐TS‐10 | An Unsupervised Learning Approach to Identify Immunoglobulin Utilization Patterns Using Electronic Health Records. Transfusion. 63:261A-262A. 2023
- Refractory immune thrombocytopenia in adults: Towards a new definition. British Journal of Haematology. 203:23-27. 2023
- Immunoglobulin utilization in Canada: a comparative analysis of provincial guidelines and a scoping review of the literature. Allergy, Asthma and Clinical Immunology. 19:85. 2023
- Investigation of anti-PF4 versus anti-PF4/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT. Journal of Thrombosis and Haemostasis. 21:2268-2276. 2023
- Impact of iron supplementation on patient outcomes for women with abnormal uterine bleeding: a protocol for a systematic review and meta-analysis. Systematic Reviews. 12:121. 2023
- Huynh A, Arnold DM, Michael JV, et al. Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S. Blood Adv. 2023;7(2):246-250.. Blood Advances. 7:3113-3113. 2023
- Erratum. Transfusion. 63:1412-1412. 2023
- Adjudicating the Diagnosis of Immune Thrombocytopenia in a Clinical Research Study. TH Open. 07:e105-e109. 2023
- Adjudicating the Diagnosis of Immune Thrombocytopenia in a Clinical Research Study. TH Open. 07:e105-e109. 2023
- Adjudicating the Diagnosis of Immune Thrombocytopenia in a Clinical Research Study. TH Open. 7:e105-e109. 2023
- Adjudicating the Diagnosis of Immune Thrombocytopenia in a Clinical Research Study. TH Open. 7:e105-e109. 2023
- Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder. International Journal of Hematology. 117:341-348. 2023
-
Lessons learned from the
CONCOR ‐1 trial. Transfusion Medicine. 33:21-25. 2023 - Proceedings of the immune thrombocytopenia summit: new concepts in mechanisms, diagnosis, and management. Research and Practice in Thrombosis and Haemostasis. 7:100097-100097. 2023
- Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S. Blood Advances. 7:246-250. 2023
- “Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia”: reply. Journal of Thrombosis and Haemostasis. 21:185-185. 2023
-
A
data‐informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma. Transfusion. 62:2525-2538. 2022 - Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 20:2988-2997. 2022
- Longitudinal Characteristics of Anti-Platelet Factor 4 Immunoglobulin G in Vaccine-Induced Immune Thrombotic Thrombocytopenia. Blood. 140:5640-5641. 2022
- Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia. Transfusion. 62:2213-2222. 2022
- Continuing Medical Education. Transfusion. 62:2212-2212. 2022
- Longitudinal Characteristics of Anti-Platelet Factor 4 Immunoglobulin G in Vaccine-Induced Immune Thrombotic Thrombocytopenia. Blood. 140:5640-5641. 2022
- Plasma transfusion practices: A multicentre electronic audit. Vox Sanguinis. 117:1211-1219. 2022
- Polarimetry and photometry of gamma-ray bursts afterglows with RINGO3. Monthly Notices of the Royal Astronomical Society. 516:1584-1600. 2022
- Frequency and utility of bone marrow examination in relapsed/refractory immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 20:2119-2126. 2022
- Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil. Vaccine. 40:4788-4795. 2022
- The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia. Blood Advances. 6:4228-4235. 2022
- Database‐driven research and big data analytic approaches in transfusion medicine. Transfusion. 62:1427-1434. 2022
- Transfusion thresholds in myelodysplastic syndrome—Helping patients live better. Transfusion. 62:1313-1314. 2022
- Heparin or nonheparin anticoagulants for VITT. Blood. 139:3358-3359. 2022
- Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open‐label study. American Journal of Hematology. 97:691-699. 2022
- SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia. Blood Advances. 6:2250-2253. 2022
- Post-cardiac surgery thrombotic thrombocytopenic purpura: presence of anti-ADAMTS13 autoantibodies at preoperative baseline. Platelets. 33:479-483. 2022
- Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT). Seminars in Hematology. 59:89-96. 2022
- Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. Blood Advances. 6:785-792. 2022
- Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Nature Medicine. 28:212-212. 2022
- From demand forecasting to inventory ordering decisions for red blood cells through integrating machine learning, statistical modeling, and inventory optimization. Transfusion. 62:87-99. 2022
- Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19. Nature Medicine. 28:53-58. 2022
- T cell–mediated autoimmunity in immune thrombocytopenia. European Journal of Haematology. 108:18-27. 2022
- Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis. Frontiers in Cardiovascular Medicine. 9:1040196. 2022
- GRB 191016A: a highly collimated gamma-ray burst jet with magnetized energy injection. Monthly Notices of the Royal Astronomical Society. 509:5964-5973. 2021
- Lessons from vaccine-induced immune thrombotic thrombocytopenia. Nature Reviews Immunology. 21:753-755. 2021
- Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia. Advances in Therapy. 38:5791-5808. 2021
- Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Thrombosis and Haemostasis. 121:1677-1680. 2021
- Perioperative Anemia Management in Women Undergoing Gynecologic Procedures: A 10 Year Multisite Study. Blood. 138:752-752. 2021
- Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19. Journal of the American Medical Association (JAMA). 326:1690-1690. 2021
- Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia. Blood Advances. 5:4256-4264. 2021
- All-trans retinoic acid for treating immune thrombocytopenia: new purpose for an old drug?. The Lancet Haematology. 8:e672-e673. 2021
- Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis. The BMJ. 374:n2231-n2231. 2021
- Extensive variability in platelet, bleeding, and QOL outcome measures in adult and pediatric ITP: Communication from the ISTH SSC subcommittee on platelet immunology. Journal of Thrombosis and Haemostasis. 19:2348-2354. 2021
- Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature. 596:565-569. 2021
- Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia. New England Journal of Medicine. 385:720-728. 2021
- Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology. Journal of Thrombosis and Haemostasis. 19:2082-2088. 2021
- Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI). British Journal of Haematology. 194:759-766. 2021
- The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters. Journal of Thrombosis and Haemostasis. 19:2094-2095. 2021
- Reconnaître, traiter et signaler les cas de thrombocytopénie immunitaire thrombotique induite par un vaccin. CANADIAN MEDICAL ASSOCIATION JOURNAL. 193:E1031-E1033. 2021
- Anemia-Induced Bleeding in Patients with Platelet Disorders. Transfusion Medicine Reviews. 35:22-28. 2021
- Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria. British Journal of Haematology. 194:439-443. 2021
- Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia. CANADIAN MEDICAL ASSOCIATION JOURNAL. 193:E913-E915. 2021
- Recommendations for the clinical and laboratory diagnosis of VITT against COVID‐19: Communication from the ISTH SSC Subcommittee on Platelet Immunology. Journal of Thrombosis and Haemostasis. 19:1585-1588. 2021
- Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial. Trials. 22:323. 2021
- Platelet‐activating immune complexes identified in critically ill COVID‐19 patients suspected of heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 19:1342-1347. 2021
-
Thrombocytopenia following Pfizer and Moderna
SARS‐CoV ‐2 vaccination. American Journal of Hematology. 96:534-537. 2021 - Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects. Viruses. 13:697-697. 2021
- A comparative study of platelet factor 4‐enhanced platelet activation assays for the diagnosis of heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 19:1096-1102. 2021
-
Serotonin‐release assay‐positive but platelet factor 4‐dependent enzyme‐immunoassay negative:
HIT or notHIT ?. American Journal of Hematology. 96:320-329. 2021 -
Immune thrombocytopenia (
ITP )World Impact Survey (I‐WISh ): Impact ofITP on health‐related quality of life. American Journal of Hematology. 96:199-207. 2021 - Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment. American Journal of Hematology. 96:188-198. 2021
- Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy. Transfusion. 61:286-293. 2021
- International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee. Journal of Thrombosis and Haemostasis. 19:287-296. 2021
- Platelet Activating Immune Complexes Identified in COVID-19 Associated Coagulopathy 2020
- Extensive Variability in Platelet Count, Bleeding, and Quality of Life Outcome Measures in Adult and Pediatric Immune Thrombocytopenia: An Appraisal from a Critical Review of the Literature. Blood. 136:45-46. 2020
- Cluster‐randomized trials in transfusion medicine. Transfusion. 60:2470-2473. 2020
- The mega-importance of de novo lipogenesis in platelet production. Nature Metabolism. 2:999-1000. 2020
- The role of fluid-phase immune complexes in the pathogenesis of heparin-induced thrombocytopenia. Thrombosis Research. 194:135-141. 2020
- Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. The Lancet Haematology. 7:e640-e648. 2020
- Platelet factor 4 inhibits ADAMTS13 activity and regulates the multimeric distribution of von Willebrand factor. British Journal of Haematology. 190:594-598. 2020
- Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome. Blood Advances. 4:3368-3377. 2020
- Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia. Blood Advances. 4:2962-2966. 2020
- Combination of two complementary automated rapid assays for diagnosis of heparin‐induced thrombocytopenia (HIT). Journal of Thrombosis and Haemostasis. 18:1435-1446. 2020
- Increased cytotoxic potential of CD8+ T cells in immune thrombocytopenia. British Journal of Haematology. 188:e72-e76. 2020
- Serotonin‐release assay‐negative heparin‐induced thrombocytopenia. American Journal of Hematology. 95:38-47. 2020
- American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Advances. 3:3829-3866. 2019
- Premedication for the prevention of nonhemolytic transfusion reactions: a systematic review and meta‐analysis. Transfusion. 59:3609-3616. 2019
- Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Advances. 3:3780-3817. 2019
- A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia. Platelets. 30:1017-1021. 2019
- Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Internal Medicine. 179:1469-1469. 2019
- Postnatal intervention for the treatment of FNAIT: a systematic review. Journal of Perinatology. 39:1329-1339. 2019
- Corrigendum. Journal of Thrombosis and Haemostasis. 17:1578-1578. 2019
- First-Line Therapy for Immune Thrombocytopenia. Hamostaseologie. 39:259-265. 2019
- Timeline of heparin‐induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay. International Journal of Laboratory Hematology. 41:493-502. 2019
- PF427 FOSTAMATINIB, A SPLEEN TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA: INITIAL RESULTS OF THE OPEN‐LABEL EXTENSION PERIOD OF THE SOAR PHASE 2 STUDY. HemaSphere. 3:167-167. 2019
- PF703 LONG‐TERM FOSTAMATINIB TREATMENT OF ADULTS WITH IMMUNE THROMBOCYTOPENIA (ITP) DURING THE PHASE 3 CLINICAL TRIAL PROGRAM. HemaSphere. 3:306-306. 2019
- The association between platelet transfusions and mortality in patients with critical illness. Transfusion. 59:1962-1970. 2019
- Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence‐based practice, an international approach. British Journal of Haematology. 185:549-562. 2019
- Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program. American Journal of Hematology. 94:546-553. 2019
- The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta‐analysis of a diagnostic test. Journal of Thrombosis and Haemostasis. 17:787-794. 2019
- Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale. Thrombosis and Haemostasis. 119:500-507. 2019
- Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 17:389-399. 2019
- The association between blood donor sex and age and transfusion recipient mortality: an exploratory analysis. Transfusion. 59:482-491. 2019
-
Maternal
HPA ‐1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review. Vox Sanguinis. 114:79-94. 2019 - The new 4‐m robotic telescope. Astronomische Nachrichten. 340:40-45. 2019
- Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score. Blood. 132:2684-2686. 2018
- Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 16:2526-2529. 2018
- How do we diagnose immune thrombocytopenia in 2018?. Hematology. American Society of Hematology. Education Program. 2018:561-567. 2018
- Fluid-Phase Immune Complexes Can Assemble and Activate Platelets in Heparin-Induced Thrombocytopenia. Blood. 132:3746-3746. 2018
- Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin. Transfusion. 58:2729-2735. 2018
- Megakaryocyte apoptosis in immune thrombocytopenia. Platelets. 29:729-732. 2018
- High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT. Blood. 132:1345-1349. 2018
- Erratum to: The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant who Need an Elective Surgery or Procedure: Design and Rationale. Thrombosis and Haemostasis. 118:1679-1680. 2018
- The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations. Clinical Biochemistry. 58:53-59. 2018
- Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 16:1402-1412. 2018
- Cyclic thrombocytopenia with statistically significant neutrophil oscillations. Clinical Case Reports. 6:1347-1352. 2018
- Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials. American Journal of Hematology. 93:921-930. 2018
- Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay. Chest. 153:1396-1404. 2018
- The Use of Anticoagulation in Patients With Thrombocytopenia. Blood. 15. 2018
- Development of a high-yield expression and purification system for platelet factor 4. Platelets. 29:249-256. 2018
- Splenectomy for immune thrombocytopenia: down but not out. Blood. 131:1172-1182. 2018
- Early Warning Scores do not accurately predict mortality in sepsis: A meta-analysis and systematic review of the literature. Journal of Infection. 76:241-248. 2018
- Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry. Blood Advances. 1:2414-2420. 2017
- Red blood cell storage and in-hospital mortality: a secondary analysis of the INFORM randomised controlled trial. The Lancet Haematology. 4:e544-e552. 2017
- A novel primary-specialist care collaborative demonstration project to improve the access and health care of medically complex patients. Chronic Illness. 13:151-170. 2017
- How we treat thrombotic thrombocytopenic purpura: Results of a Canadian TTP practice survey. Journal of Clinical Apheresis. 32:246-256. 2017
- A simple, field-friendly technique for cryopreserving semen from Asian elephants (Elephas maximus). Animal Reproduction Science. 182:84-94. 2017
- The effect of rituximab on anti‐platelet autoantibody levels in patients with immune thrombocytopenia. British Journal of Haematology. 178:302-307. 2017
-
Group O
RBC s: where is universal donor blood being used. Vox Sanguinis. 112:336-342. 2017 - Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL ® HIT-Ab (PF4-H) ] for the diagnosis of immune heparin-induced thrombocytopenia. Thrombosis Research. 153:108-117. 2017
- The unique immunological features of heparin‐induced thrombocytopenia. British Journal of Haematology. 177:198-207. 2017
- Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review. Blood. 129:1538-1547. 2017
- Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study. Transfusion. 57:525-532. 2017
- Thrombotic microangiopathies: a general approach to diagnosis and management. CANADIAN MEDICAL ASSOCIATION JOURNAL. 189:E153-E159. 2017
- Paroxysmal cold hemoglobinuria: a difficult diagnosis in adult patients. Transfusion. 57:137-143. 2017
- The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale. Thrombosis and Haemostasis. 117:2415-2424. 2017
- Autoantibodies to Thrombopoietin and the Thrombopoietin Receptor in Patients with Immune Thrombocytopenia. Blood. 128:2548-2548. 2016
- Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion. New England Journal of Medicine. 375:1937-1945. 2016
- High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis. The Lancet Haematology. 3:e489-e496. 2016
- Transfusion‐related alloimmunization in children: epidemiology and effects of chemotherapy. Vox Sanguinis. 111:299-307. 2016
- Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy. Blood. 128:1329-1335. 2016
-
EP21.08: Antenatal management of fetal neonatal alloimmune thrombocytopenia (
FNAIT ) and neonatal outcome according to the category of risk. Ultrasound in Obstetrics and Gynecology. 48:358-358. 2016 - Difficulties in establishing the diagnosis of immune thrombocytopenia: An agreement study. American Journal of Hematology. 91:E327-E329. 2016
- An evaluation of overall effectiveness and treatment satisfaction with intravenous immunoglobulin among patients with immune thrombocytopenia. Transfusion. 56:1739-1744. 2016
- Understanding intravenous iron ordering practices for inpatients and outpatients at a large academic institution. Transfusion Medicine Reviews. 30:147-147. 2016
- Producing megakaryocytes from a human peripheral blood source. Transfusion. 56:1066-1074. 2016
- Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort study. The Lancet Haematology. 3:e246-e254. 2016
- Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort study. The Lancet Haematology. 3:E246-E254. 2016
- Triplets with neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1a. Transfusion. 56:1166-1170. 2016
- Design and Implementation of a Competency-Based Transfusion Medicine Training Program in Canada. Transfusion Medicine Reviews. 30:30-36. 2016
- Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia. Transfusion. 56:73-79. 2016
- Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry. Chest. 150:516-523. 2016
- Rationale and Design of the Informing Fresh versus Old Red Cell Management (INFORM) Trial: An International Pragmatic Randomized Trial. Transfusion Medicine Reviews. 30:25-29. 2016
- Bleeding complications in immune thrombocytopenia. Hematology. American Society of Hematology. Education Program. 2015:237-242. 2015
- Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia. European Journal of Haematology. 95:532-537. 2015
- Distinguishing between anti–platelet factor 4/heparin antibodies that can and cannot cause heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 13:1900-1907. 2015
- Scholarly Success Among Internal Medicine Residents in Canada. Canadian Journal of General Internal Medicine. 10:33-37. 2015
- Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review: reply. Journal of Thrombosis and Haemostasis. 13:1522-1523. 2015
- A phase‐II sequential case‐series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab. British Journal of Haematology. 170:208-217. 2015
- Pitfalls in the diagnosis of heparin‐Induced thrombocytopenia: A 6‐year experience from a reference laboratory. American Journal of Hematology. 90:629-633. 2015
- The platelet serotonin‐release assay. American Journal of Hematology. 90:564-572. 2015
- Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study. Vox Sanguinis. 108:274-280. 2015
- Recommendations for standardization of laboratory testing for drug‐induced immune thrombocytopenia: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 13:676-678. 2015
- Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia. American Journal of Hematology. 90:271-272. 2015
- Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. Journal of Thrombosis and Haemostasis. 13:457-464. 2015
- Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis. The Lancet Haematology. 2:e75-e81. 2015
- Plasma transfusion trials and tribulations. Transfusion. 55:14-16. 2015
- Low Level Platelet-Activating Antibodies in Patients Suspected of Having Heparin-Induced Thrombocytopenia but Testing Negative in the ”Gold Standard” Functional Test. Blood. 124:2757-2757. 2014
- The nature of the late achromatic bump in GRB 120326A. Astronomy and Astrophysics (A & A). 572:A55-A55. 2014
- Understanding why patients with immune thrombocytopenia are deeply divided on splenectomy. Health Expectations. 17:809-817. 2014
- γT‐S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo. Journal of Thrombosis and Haemostasis. 12:1110-1115. 2014
- How to Succeed in Research During Medical Training: A Qualitative Study. Clinical and Investigative Medicine. 37:117-117. 2014
- Novel treatments for immune thrombocytopenia. Presse Medicale. 43:e87-e95. 2014
- Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulin. Transfusion. 54:640-645. 2014
- Platelet transfusions for critically ill patients with thrombocytopenia. Blood. 123:1146-1151. 2014
- Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis. Intensive Care Medicine. 39:2135-2143. 2013
- The effects of rituximab on serum IgE and BAFF. Allergy, Asthma and Clinical Immunology. 9:39. 2013
- The Use Of Platelet Transfusions In The Intensive Care Unit and Impact On Platelet Count: A 30,000 Patient Registry Study. Blood. 122:1154-1154. 2013
- Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists. Transfusion. 53:2807-2812. 2013
- Thrombocytopenia in Critically Ill Patients Receiving Thromboprophylaxis. Chest. 144:1207-1215. 2013
-
Utilization of frozen plasma in
O ntario: a provincewide audit reveals a high rate of inappropriate transfusions. Transfusion. 53:2222-2229. 2013 - The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood. 122:1946-1953. 2013
- Condensation reactions of guanidines with bis-electrophiles: formation of highly nitrogenous heterocycles. Tetrahedron. 69:7719-7731. 2013
- A platelet cover-up. Blood. 122:307-309. 2013
- Approach to the Diagnosis and Management of Drug-Induced Immune Thrombocytopenia. Transfusion Medicine Reviews. 27:137-145. 2013
- FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 11:1146-1153. 2013
- Indecomposable (1,3)-Groups and a matrix problem. Czechoslovak Mathematical Journal. 63:307-355. 2013
- Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness. Thrombosis Research. 131:204-209. 2013
- Asthma Associated With Incontinentia Pigmenti and Fanconi Anemia. Chest. 143:856-858. 2013
- Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia. New England Journal of Medicine. 368:737-744. 2013
- A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia. European Journal of Haematology. 90:121-126. 2013
- A systematic evaluation of laboratory testing for drug‐induced immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 11:169-176. 2013
- Positioning new treatments in the management of immune thrombocytopenia. Pediatric Blood and Cancer. 60:S19-S22. 2013
- 118. Critical Care Medicine. 40:1-328. 2012
- 337. Critical Care Medicine. 40:1-328. 2012
- Leaving nothing to chance: how to randomize a clinical trial. Transfusion. 52:2513-2515. 2012
- Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura. Transfusion. 52:2517-2523. 2012
- A new tool to assess bleeding severity in patients with chemotherapy‐induced thrombocytopenia (CME). Transfusion. 52:2466-2474. 2012
-
Continuing Medical Education Program in
T ransfusion. Transfusion. 52:2465-2465. 2012 - Platelet count or bleeding as the outcome in ITP trials?. American Journal of Hematology. 87:945-946. 2012
- Immune thrombocytopenia: Getting back to basics. American Journal of Hematology. 87:841-842. 2012
- Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate. Journal of Thrombosis and Haemostasis. 10:1830-1840. 2012
- A prospective study measuring the development of antibodies against platelet factor 4–heparin in healthy males after exposure to heparins. Journal of Thrombosis and Haemostasis. 10:1446-1449. 2012
- The effect of blood storage duration on in‐hospital mortality: a randomized controlled pilot feasibility trial. Transfusion. 52:1203-1212. 2012
- Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 10:695-697. 2012
- A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia. Blood. 119:1356-1362. 2012
- In medical-surgical ICU patients, major bleeding is common but independent of heparin prophylaxis. Critical Care. 16:P435-P435. 2012
- Elicitation of utility scores in Canada for immune thrombocytopenia treated with romiplostim or watch and rescue. Journal of Medical Economics. 15:313-331. 2012
- A multifaceted strategy to reduce inappropriate use of frozen plasma transfusions in the intensive care unit. Journal of Critical Care. 26:636.e7-636.e13. 2011
- Bone Marrow Specimens From Patients with Immune Thrombocytopenia (ITP) Demonstrate Increased Megakaryocyte-Bound IgG and Increased T-Helper Cells. Blood. 118:2233-2233. 2011
- Identifying Drugs Implicated in Drug-Induced Immune Thrombocytopenia Using Levels of Evidence Applied to Laboratory Tests,. Blood. 118:3304-3304. 2011
- Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges. Transfusion. 51:2304-2310. 2011
- A Rational Approach to the Diagnosis and Management of Thrombocytopenia in the Hospitalized Patient. Seminars in Hematology. 48:251-258. 2011
- Consent in critical care trials: a survey of Canadian research ethics boards and critical care researchers. Journal of Critical Care. 26:533.e11-533.e22. 2011
- Piecing Together the Humoral and Cellular Mechanisms of Immune Thrombocytopenia. Seminars in Vascular Medicine. 37:631-639. 2011
- Survival of trauma patients after massive red blood cell transfusion using a high or low red blood cell to plasma transfusion ratio*. Critical Care Medicine. 39:1507-1513. 2011
- The association between platelet activation and FcγRIIa proteolysis. Journal of Thrombosis and Haemostasis. 9:885-887. 2011
- Bias in transfusion research: from study design to result reporting. Transfusion. 51:237-240. 2011
- The Frequency and Clinical Significance of Thrombocytopenia Complicating Critical Illness. Chest. 139:271-278. 2011
- Time to rethink clinically important outcomes in platelet transfusion trials. Transfusion. 51:430-434. 2011
- Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters. British Journal of Haematology. 152:52-60. 2011
- Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia. Transfusion. 50:2577-2581. 2010
- The Frequency and Clinical Significance of Thrombocytopenia Complicating Critical Illness: A Systematic Review. Blood. 116:4664-4664. 2010
- The Utility of Bone Marrow Examinations for the Diagnosis of Immune Thrombocytopenia.. Blood. 116:3691-3691. 2010
- Understanding Treatment Preferences In Patients with Primary Immune Thrombocytopenia Contemplating Splenectomy: A Qualitative Study. Blood. 116:392-392. 2010
- ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. Journal of Thrombosis and Haemostasis. 8:2063-2065. 2010
- A framework for resolving disagreement during end of life care in the critical care unit. Clinical and Investigative Medicine. 33:240-240. 2010
- Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices. Transfusion. 50:1722-1730. 2010
- Preoperative risk assessment for bleeding and thromboembolism. Praxis. 99:609-611. 2010
- Präoperative Bewertung des Blutungs- und Thromboseembolierisikos. Praxis: a journal of writing and building. 99:609-612. 2010
- Comparative Genome Analysis Provides Insights into the Evolution and Adaptation of Pseudomonas syringae pv. aesculi on Aesculus hippocastanum. PLoS ONE. 5:e10224-e10224. 2010
- The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases. British Journal of Haematology. 149:3-13. 2010
- Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura. Blood. 115:29-31. 2010
- A Multifaceted Strategy to Reduce Inappropriate Use of Fresh Frozen Plasma Transfusions in the Intensive Care Unit.. Blood. 114:1412-1412. 2009
- Adjudicating Bleeding Outcomes in a Large Thromboprophylaxis Trial in Critical Illness.. Blood. 114:2471-2471. 2009
- Passive Transfer of Hepatitis B Core Antibody by Intravenous Immune Globulin in Patients with Immune Thrombocytopenic Purpura.. Blood. 114:2418-2418. 2009
- Spectral Analysis of Platelet Oscillations in Cyclic Thrombocytopenia.. Blood. 114:4459-4459. 2009
- Preoperative risk assessment for bleeding and thromboembolism. The BMJ. 339:b2299-b2299. 2009
- Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency. Current Opinion in Pulmonary Medicine. 15:455-462. 2009
- ERRATA. Transfusion. 49:2012-2012. 2009
- Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses (vol 46, pg 1286, 2006). Transfusion. 49:2012-2012. 2009
- Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis. The BMJ. 339:b2688-b2688. 2009
- Pilot trials in transfusion medicine. Transfusion. 49:1293-1295. 2009
- New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses. Expert Opinion on Investigational Drugs. 18:805-819. 2009
- Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Hematology Journal. 94:850-856. 2009
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 113:2386-2393. 2009
- The design and interpretation of pilot trials in clinical research in critical care. Critical Care Medicine. 37:S69-S74. 2009
- Autoantibodies in Patients with ITP Do Not Bind to Patient-Specific Epitopes on Platelet Glycoproteins.. Blood. 112:3427-3427. 2008
- The Efficacy of H. pylori Eradication Therapy in H. pylori-Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review.. Blood. 112:3413-3413. 2008
- Delayed‐onset HIT caused by low‐molecular‐weight heparin manifesting during fondaparinux prophylaxis. American Journal of Hematology. 83:876-878. 2008
- Diagnosis and Management of Neonatal Alloimmune Thrombocytopenia. Transfusion Medicine Reviews. 22:255-267. 2008
- An algorithm for resolving ‘indeterminate’ test results in the platelet serotonin release assay for investigation of heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 6:1595-1597. 2008
- “Spare-spleen-uximab” for chronic ITP. Blood. 112:925-926. 2008
- The use and abuse of surrogate endpoints in clinical research in transfusion medicine. Transfusion. 48:1547-1549. 2008
- Comparing the efficacy and safety of apheresis and whole blood–derived platelet transfusions: a systematic review. Transfusion. 48:1447-1458. 2008
- Does Helicobacter pylori Eradication Therapy Result in a Platelet Count Improvement in Adults with Immune Thrombocytopenic Purpura Regardless of H pylori Infection?. Hematology. American Society of Hematology. Education Program. 2008:31-32. 2008
- Evidence-Based Guidelines—An Introduction. Hematology. American Society of Hematology. Education Program. 2008:26-30. 2008
- SUBGROUPS OF FINITE DIRECT SUMS OF Z[1/n]. Houston Journal of Mathematics. 34:997-1007. 2008
- An Individual Platelet Count Set-Point in ITP: A Concept Learned from Patients with Mild Thrombocytopenia and a Good Response to IVIg or Corticosteroids.. Blood. 110:3926-3926. 2007
- Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura. Seminars in Hematology. 44:S12-S23. 2007
- Representations of Finite Posets Over Discrete Valuation Rings. Communications in Algebra. 35:3128-3144. 2007
- Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia. Haemophilia. 13:518-526. 2007
- In response. Annals of Internal Medicine. 147:281-282. 2007
- Rituximab for Patients with Idiopathic Thrombocytopenic Purpura. ACP journal club. 147:281-281. 2007
- Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura. Vox Sanguinis. 93:173-175. 2007
- The science of systematic reviews. Transfusion. 47:1347-1349. 2007
- Testing for heparin‐induced thrombocytopenia: are we there yet?. Journal of Thrombosis and Haemostasis. 5:1371-1372. 2007
- Trends in the utilization and wastage of coagulation factor concentrates: the application of a regional tracking programme. Haemophilia. 13:271-278. 2007
- Passive Transfer of Peanut Hypersensitivity by Fresh Frozen Plasma. JAMA Internal Medicine. 167:853-853. 2007
- Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura. ACP journal club. 146:25-25. 2007
- Bleeding during critical illness: A prospective cohort study using a new measurement tool. Clinical and Investigative Medicine. 30:93-93. 2007
- Synthesis and Biological Activity of a Focused Library of Mitogen‐activated Protein Kinase Phosphatase Inhibitors. Chemical Biology and Drug Design. 69:23-30. 2007
- Pure Submodules of Finite Direct Sums of Co-Purely Indecomposable Modules. Communications in Algebra. 35:355-369. 2006
- An Algorithm for “Indeterminate” Test Results in the Platelet Serotonin Release Assay for Heparin-Induced Thrombocytopenia (HIT).. Blood. 108:1048-1048. 2006
- Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses. Transfusion. 46:1286-1291. 2006
- Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-up. Blood. 108:460-464. 2006
- Representations of finite partially ordered sets over commutative artinian uniserial rings. Journal of Pure and Applied Algebra. 205:640-659. 2006
- Avoiding Transfusions in Children Undergoing Cardiac Surgery: A Meta-Analysis of Randomized Trials of Aprotinin. Anesthesia and Analgesia. 102:731-737. 2006
- In vivo recovery and survival of apheresis and whole blood‐derived platelets: a paired comparison in healthy volunteers. Transfusion. 46:257-264. 2006
- Mixed modules of finite torsion-free rank over a discrete valuation domain. Forum Mathematicum. 18:85-98. 2006
- Pi-balanced torsion-free modules over a discrete valuation domain. Journal of Algebra. 295:269-288. 2006
- Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Journal of Critical Care. 20:348-353. 2005
- Rituximab for the Treatment of Adults with ITP: A Systematic Review.. Blood. 106:1241-1241. 2005
- Heparin-Induced Thrombocytopenia: An Iceberg Rising. Mayo Clinic proceedings. 80:988-990. 2005
- Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infection. Transfusion. 45:394-398. 2005
- Endo-wild representation type and generic representations of finite posets. Pacific Journal of Mathematics. 219:1-26. 2005
- Survival of HIV Infected Individuals with Hemophilia after 20 Years: From the Canadian Hemophilia Registry.. Blood. 104:3085-3085. 2004
- Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage. Transfusion. 44:1361-1366. 2004
- Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies. American Journal of Hematology. 76:373-377. 2004
- Torsion-free modules of finite rank over a discrete valuation ring. Journal of Algebra. 272:456-469. 2004
- Thrombocytopenia in medical–surgical ICU patients. Critical Care. 8:P125-P125. 2004
- Proceedings of the second Honolulu Conference on Abelian Groups and Modules. Rocky Mountain Journal of Mathematics. 32:1057-1059. 2002
- Direct sums of local torsion-free abelian groups. Proceedings of the American Mathematical Society. 130:1611-1617. 2002
- Finite rank Butler groups and torsion-free modules over a discrete valuation ring. Proceedings of the American Mathematical Society. 129:325-335. 2001
- Enterocutaneous Fistula Complicating Total Hip Arthroplasty. Clinical Orthopaedics and Related Research. 278:108???110-108???110. 1992
- Surgical management of chronic ulnar collateral ligament insufficiency of the thumb metacarpophalangeal joint.. Orthopaedic Review. 21:583-588. 1992
- Isomorphism invariants for abelian groups. Transactions of the American Mathematical Society. 330:711-724. 1992
- Field-independent representations of partially ordered sets. Forum Mathematicum. 4:349-357. 1992
- Almost Split Sequences for Dedekind-Like Rings. Journal of the London Mathematical Society. s2-43:225-235. 1991
- Duality and invariants for Butler groups. Pacific Journal of Mathematics. 148:1-10. 1991
- Logging calibration technology and facilities. IEEE Transactions on Nuclear Science. 35:844-846. 1988
- Natural gamma ray spectroscopy applied to borehole measurements. IEEE Transactions on Nuclear Science. 35:822-826. 1988
- Endomorphism rings of Butler groups. Journal of the Australian Mathematical Society. Series A. Pure mathematics and statistics. 42:322-329. 1987
- A Finite Global Azumaya Theorem in Additive Categories. Proceedings of the American Mathematical Society. 91:25-25. 1984
- Endomorphism rings and subgroups of finite rank torsion-free Abelian groups. Rocky Mountain Journal of Mathematics. 12:241-256. 1982
- FINITE RANK TORSION FREE ABELIAN-GROUPS AND RINGS. Lecture Notes in Mathematics. 931:R3-189. 1982
- Quasi-Pure Injective and Projective Torsion-Free Abelian Groups of Finite Rank. Proceedings of the London Mathematical Society. s3-38:532-544. 1979
- STRONGLY HOMOGENEOUS TORSION FREE ABELIAN-GROUPS OF FINITE RANK. Proceedings of the American Mathematical Society. 56:67-72. 1976
- P1589: PATIENT (PT) AND PHYSICIAN (MD) PERCEPTIONS OF THE BURDEN OF IMMUNE THROMBOCYTOPENIA (ITP) AND ITS MANAGEMENT: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH) 2.0. HemaSphere. 7:e36093e7-e36093e7.
- Second-Line Therapy for Immune Thrombocytopenia: Real-World Experience in Canada. Canadian Journal of General Internal Medicine. 15:28-35.
- THE 4 M NEW ROBOTIC TELESCOPE PROJECT: AN UPDATED REPORT. Revista Mexicana de Astronomia y Astrofisica: Serie de Conferencias. 53:8-13.
-
preprints
- Cost-Effectiveness of Convalescent Plasma for COVID-19: A Cost-effectiveness Analysis of the CONCOR-1 Randomized Trial 2023
- Polarimetry and Photometry of Gamma-Ray Bursts Afterglows with RINGO3 2022
- GRB 191016A: A highly collimated gamma-ray burst jet with magnetised energy injection 2021
- Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial 2021
- Data-driven Fair Resource Allocation For Novel Emerging Epidemics: A COVID-19 Convalescent Plasma Case Study 2021
- Characteristics of anti-SARS-CoV-2 antibodies in recovered COVID-19 subjects 2020
- A Non-Inferiority Trial of Perioperative Eltrombopag or Intravenous Immune Globulin for Immune Thrombocytopenia 2020
- Polarimetry and Photometry of Gamma-Ray Bursts with RINGO2 2017
- Limits on optical polarization during the prompt phase of GRB 140430A 2015
- The nature of the late achromatic bump in GRB 120326A 2014